Anadolu Medical Center
Anadolu Medical Center
Turquie, Istanbul
Banu Atalar
26 années d'expérience
La clinique est certifiée :
En Turquie, le traitement du cancer de la prostate par CyberKnife coûte généralement de $25,000 à $32,000. Le tarif final dépend du nombre de séances et de la complexité de la tumeur. Les patients économisent environ 26% par rapport à la France, où le coût moyen est de $38,500. La plupart des cliniques turques incluent l'imagerie diagnostique, les transferts aéroport et l'interprétariat dans leurs forfaits oncologiques.
Avis d'expert Bookimed : Choisir un centre hospitalier universitaire, comme Medipol Mega ou Anadolu, garantit une sécurité optimale. Ces établissements sont accrédités JCI et OECI, assurant des normes de sécurité internationales. Medipol Mega propose le CyberKnife pour environ 7 100 €, planification du traitement incluse. Anadolu offre une valeur ajoutée grâce à son affiliation avec l'hôpital Johns Hopkins. Pour des options plus économiques, Memorial Şişli propose des forfaits à partir de 4 950 €. Cela inclut généralement l'intervention, les transferts et le service de traduction médicale.
Pourquoi choisir la Turquie pour un traitement CyberKnife du cancer de la prostate ?
Accédez à des solutions avancées CyberKnife pour le cancer de la prostate dans des cliniques de confiance .
| Turquie | Espagne | Allemagne | |
| CyberKnife pour le cancer de la prostate | de $25,000 | de $15,000 | de $30,000 |
Jour 1 : Arrivée
Jour 2 : Pré-opération
Jour 3 : Jour de repos
Jour 4 : Traitement CyberKnife
Jour 5 : Post-traitement
Jour 6 : Décharge
Semaine 1-2 : Rééducation
Semaine 3-4 : Retour au travail
Veuillez noter que le calendrier ci-dessus est une ligne directrice générale et que les expériences individuelles peuvent varier en fonction de situations cliniques spécifiques. Consultez toujours votre professionnel de la santé pour obtenir des conseils personnalisés.
Spécialisé dans le traitement du cancer de la prostate par CyberKnife à l'hôpital Hisar Intercontinental – formé à l'Institut du cancer de l'université Hacettepe.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Le Dr Hasan Mutlu apporte plus d'une décennie d'expérience spécialisée en oncologie médicale aux traitements CyberKnife pour le cancer de la prostate.
Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.
He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.
Success rates for CyberKnife prostate cancer treatment in Turkey range from 85% to 97% for localized cases. This non-invasive robotic radiosurgery achieves 98% targeting accuracy at JCI-accredited centers like Anadolu Medical Center, where specialists utilize 5-session protocols to deliver high-dose radiation while sparing healthy tissue.
Bookimed Expert Insight: Anadolu Medical Center stands out because its radiation oncologists, like Professor Banu Atalar, received direct mentorship from the CyberKnife inventor at Stanford. This specific expertise contributes to high success rates. While costs range from $25,000 to $32,000, patients save about 48% compared to average US prices of $55,000.
Patient Consensus: Patients report that outcomes are comparable to US trials, specifically noting that temporary side effects like erectile dysfunction often resolve within 6 months. Many emphasize the importance of requesting personal outcome logs and planning for PSA monitoring 18 to 24 months after the procedure.
Anadolu Medical Center, Medipol Mega University Hospital, and Memorial Sisli Hospital are Turkey's premier centers for CyberKnife prostate cancer therapy. These facilities maintain Joint Commission International accreditation and use high-precision robotic radiosurgery to deliver targeted radiation with 85% to 97% success rates for localized cases.
Bookimed Expert Insight: While many choose Turkey for the 48% savings compared to US costs, the real advantage is the equipment density. Centers like Medipol Mega and Anadolu house multiple radiation systems like CyberKnife and TrueBeam in one building. This allows doctors to switch technologies mid-protocol if your tumor's position changes between sessions.
Patient Consensus: Patients report returning to normal activities within weeks with zero incontinence issues. Most recommend planning a 14-day stay and verifying everything includes MRI reviews before traveling.
Ideal candidates for CyberKnife prostate cancer treatment in Turkey include patients with localized, early-stage (T1-T2) disease and a Gleason score of 7 or lower. This non-invasive Stereotactic Body Radiation Therapy (SBRT) suits those seeking alternatives to surgery while maintaining an active lifestyle.
Bookimed Expert Insight: Turkish centers like Anadolu Medical Center offer a unique advantage by combining CyberKnife with MRI fusion targeting. Our data shows this precision is critical; skipping MRI fusion can increase the need for secondary salvage therapy. While US protocols are often rigid, experienced Turkish professors like Dr. Banu Atalar frequently accept borderline intermediate-risk cases that other international centers might reject.
Patient Consensus: Men emphasize that the ability to return to work within days is the primary motivator. They frequently advise others to verify that the clinic has performed over 500 successful prostate cases to ensure optimal outcomes.
CyberKnife for prostate cancer causes minimal side effects due to sub-millimeter precision. Most patients experience temporary urinary irritation, mild fatigue, or rectal pressure starting two weeks after treatment. Symptoms typically resolve within 2 to 4 weeks using over-the-counter medications to manage flow and irritation.
Bookimed Expert Insight: Anadolu Medical Center and Medipol Mega utilize 4D real-time tracking to adjust for natural prostate movement. This technology significantly reduces rectal radiation compared to standard IMRT. While US treatments average $55,000, Turkish centers offer the same robotic precision for $25,000 to $32,000.
Patient Consensus: Many patients describe the early recovery period as feeling like a bad UTI for a month. Most report returning to the gym and normal activities within 2 weeks as symptoms fade.
Patients typically need to stay in Turkey for 7 to 14 days to complete CyberKnife treatment for prostate cancer. This non-invasive robotic radiosurgery requires 1 to 5 sessions, usually scheduled daily or every other day, with no overnight hospital stays required during the outpatient process.
Bookimed Expert Insight: Our data shows top-tier centers like Anadolu Medical Center maintain a formal affiliation with Johns Hopkins Medicine. These high-volume clinics often integrate MR-guided adaptive SRS. This technology allows doctors to adjust radiation in real-time if the prostate shifts. This precision is why specialized Turkish centers can safely condense several weeks of traditional radiation into just 5 sessions.
Patient Consensus: Patients report feeling mobile immediately after sessions, though many advise booking a hotel near the clinic. Brief urinary irritation is common, so having a few buffer days before flying home helps ensure a comfortable return journey.